Commentary

Multiples remain stable in healthcare, says WCAS’s Regan; mid-market deal flow still good, says Firmament’s Boyd

WCAS GP Regan discusses healthcare investing.

Accent Equity makes reinvestment play with Inteno Group; Palisade snaps up Malaby Biogas

Ufenau portfolio company GarLa Group moves into Germany via majority stake in Bietigheimer Gartengestaltung.

BC Partners’ Wautier says 2022 could be a vintage year for PE; Apollo likes Manchester United

Thoma Bravo is opening a new office in London.

Apollo in reported talks over Man Utd stake; CapMan sees transport opportunities after early Norled exit

Earth Capital merges four bioenergy firms into Sustainable Energy Holdings.

Swander Pace extends hold over Captek Softgel; Partners Group on reinvestment in USIC

Swander Pace wraps up latest continuation fund.

Bain sees smart labelling future for Fedrigoni; Norwegian flurry as Mercell and Defero picked up

Thoma Bravo has purchased Mercell while Corsair-owned Axo bought Defero.

How physician practice companies succeed – and why some don’t

Experience teaches that aligning investors and management is particularly challenging in physician practice enterprises.

KKR closes $4bn deal for cybersecurity provider Barracuda, one of many tech deals announced today

Thoma Bravo exits Barracuda.

Thoma Bravo in early talks over Darktrace bid; GRO Capital picks up Netigate

Darktrace market cap jumps over £500m after news breaks.

FTV’s Alex Mason parses Amazon-One Medical deal; BC Partners bullish on 2023

PE Hub talks to WCAS' head of healthcare group Regan.